News

The trial aimed at blocking the virus so that patients do not need antiviral drugs, and was designed to evaluate the safety and clinical outcomes of Sangamo’s zinc

Bayer had recorded a profit of $211m in the same period of 2009, and analysts had forecast a 2010 fourth quarter profit of $219m, which did not come

Daiichi will be paying $805m up-front with near-term milestone payments associated with the approval of Plexxikon’s melanoma treatment drug PLX4032 adding up to another $130m. The acquisition will

Infusion pumps are medical devices that deliver fluids, including nutrients and medications such as antibiotics, chemotherapy drugs, and pain relievers, into a patient’s body in controlled amounts and

The latest MediHoney line extension is dispensed from a tube and is comprised of Active Manuka (Leptospermum) honey blended with natural-based gelling agents. Derma Sciences president and CEO

The acquisition close follows the Letter of Intent executed on 22 December 2010, and the SPA announced on 23 February 2011. As previously reported, the consideration for the

Matrix Laboratories, a subsidiary of Mylan, claims Gabapentin capsules USP are the genereic version of Pfizer’s treatment for painful complication of shingles, Neurontin capsules. Gabapentin capsule is an

According to the company, the new application will help the researchers in improving accuracy while assessing drug safety and effectiveness, testing for drug interactions and developing new drugs.

The patent titled ‘Healthcare information management and communications system and method,’ application makes 104 separate claims. With the filing of the full utility patent, InstaCare plans to immediately